• Sat. May 2nd, 2026

Names

  • Home
  • Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development

Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development

Classified in: Ebola virus, Health, Covid-19 virusSubject: PER Ruxandra Draghia-Akli, MD, PhD brings more than 20 years of extensive clinical, corporate and global public health expertise to support Novavax’s transition…

Kimberly Clark Names New Chief Research and Development Officer

Kimberly Clark announced that Craig Slavtcheff has been appointed chief research and development officer, effective July 29. Slavtcheff will succeed Robert Long, who is retiring from the company after 45…

Kimberly-Clark Names Craig Slavtcheff Chief Research and Development Officer

Robert Long to retire after 45 distinguished years in CPG DALLAS, July 16, 2024 /PRNewswire/ — Kimberly-Clark (NYSE: KMB) today announced that Craig Slavtcheff has been appointed Chief Research and…